{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:29:40Z","timestamp":1786980580963,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T00:00:00Z","timestamp":1522972800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s10238-018-0499-0","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T16:24:24Z","timestamp":1523031864000},"page":"355-361","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The complex alteration in the network of IL-17-type cytokines in patients with hereditary angioedema"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7153-4208","authenticated-orcid":false,"given":"Francesco","family":"Arcoleo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Lo Pizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Misiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Milano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina Colonna","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Muggeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Cillari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,6]]},"reference":[{"issue":"4","key":"499_CR1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/00005792-199207000-00003","volume":"71","author":"A Agostoni","year":"1992","unstructured":"Agostoni A, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Med (Baltimore). 1992;71(4):206\u201315.","journal-title":"Med (Baltimore)"},{"issue":"6","key":"499_CR2","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1056\/NEJMoa0906393","volume":"363","author":"M Cicardi","year":"2010","unstructured":"Cicardi M, Banerji A, Bracho F, et al. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med. 2010;363(6):532\u201341.","journal-title":"N Engl J Med"},{"key":"499_CR3","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/S0140-6736(97)09137-X","volume":"351","author":"J Nussberger","year":"1998","unstructured":"Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A. Plasma bradykinin in angio-oedema. Lancet. 1998;351:1693\u20137.","journal-title":"Lancet"},{"key":"499_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S1567-5769(02)00162-5","volume":"3","author":"M Cugno","year":"2003","unstructured":"Cugno M, Nussberger J, Cicardi M, Agostoni A. Bradykinin and the pathophysiology of angioedema. Int Immunopharmacol. 2003;3:311\u20137.","journal-title":"Int Immunopharmacol"},{"key":"499_CR5","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S0140-6736(11)60935-5","volume":"379","author":"H Longhurst","year":"2012","unstructured":"Longhurst H, Cicardi M. Hereditary angioedema. Lancet. 2012;379:474\u201381.","journal-title":"Lancet"},{"key":"499_CR6","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1056\/NEJMcp0803977","volume":"359","author":"B Zuraw","year":"2008","unstructured":"Zuraw B. Hereditary angioedema. N Engl J Med. 2008;359:1027\u201336.","journal-title":"N Engl J Med"},{"key":"499_CR7","doi-asserted-by":"publisher","first-page":"937.e17","DOI":"10.1016\/j.amjmed.2011.12.016","volume":"125","author":"A Kusuma","year":"2012","unstructured":"Kusuma A, Relan A, Knulst AC, et al. Clinical impact of peripheral attacks in hereditary angioedema patients. Am J Med. 2012;125:937.e17\u201324.","journal-title":"Am J Med"},{"key":"499_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12016-014-8463-6","volume":"50","author":"ZLM Hofman","year":"2016","unstructured":"Hofman ZLM, Relan A, Hack CE. Hereditary Angioedema attacks: local swelling at multiple sites. Clin Rev Allergy Immunol. 2016;50:34\u201340.","journal-title":"Clin Rev Allergy Immunol"},{"key":"499_CR9","doi-asserted-by":"publisher","first-page":"506","DOI":"10.2500\/aap.2009.30.3279","volume":"30","author":"MG Prematta","year":"2009","unstructured":"Prematta MG, Kemp JG, Gibbs JG, Mende C, Rhoads C, Craig TJ. Fequency, timing, and type of prodromal symptoms associated with ereditary angioedema attacks. Allergy Asthma Proc. 2009;30:506\u201311.","journal-title":"Allergy Asthma Proc"},{"key":"499_CR10","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/ced.12285","volume":"39","author":"M Magerl","year":"2014","unstructured":"Magerl M, Doumoulakis G, Kalkounou I, et al. Characterization of prodromal symptoms in a large population of patiets with hereditary angioedema. Clin Exp Dermatol. 2014;39:298\u2013303.","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"499_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/ajcp\/85.3.305","volume":"85","author":"E Cillari","year":"1986","unstructured":"Cillari E, Misiano G, Aric\u00f2 M, et al. Modification of peripheral blood T-lymphocyte surface receptors and Langerhans cell numbers in hereditary angioedema. Am J Clin Pathol. 1986;85(3):305\u201311.","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"499_CR12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0171-2985(98)80042-9","volume":"199","author":"AE Prada","year":"1998","unstructured":"Prada AE, Zahedi K, Davis AE. Regulation of C1 inhibitor synthesis. Immunobiology. 1998;199(2):377\u201388 (Review).","journal-title":"Immunobiology"},{"issue":"2","key":"499_CR13","first-page":"232","volume":"123","author":"P Gluszko","year":"1994","unstructured":"Gluszko P, Undas A, Amenta S, Szczeklik A, Schmaier AH. Administration of gamma interferon in human subjects decreases plasminogen activation and fibrinolysis without influencing C1 inhibitor. J Lab Clin Med. 1994;123(2):232\u201340.","journal-title":"J Lab Clin Med"},{"issue":"5","key":"499_CR14","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1515\/cclm-2013-1008","volume":"52","author":"F Arcoleo","year":"2014","unstructured":"Arcoleo F, Salemi M, La Porta A, et al. Upregulation of cytokines and IL-17 in patients with hereditary angioedema. Clin Chem Lab Med. 2014;52(5):e91\u20133.","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"499_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10238-015-0340-y","volume":"16","author":"M Salemi","year":"2016","unstructured":"Salemi M, Mandal\u00e0 V, Muggeo V, et al. Growth factors and IL-17 in hereditary angioedema. Clin Exp Med. 2016;16(2):213\u20138.","journal-title":"Clin Exp Med"},{"key":"499_CR16","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jaci.2016.02.041","volume":"138","author":"ZLM Hofman","year":"2016","unstructured":"Hofman ZLM, Relan A, Zeerleder S, Drouet C, Zuraw B, Hack CE. Angioedema attacks in patients with hereditary angioedema: local manifestations of a systemic activation process. J Allergy Clin Immunol. 2016;138:359\u201366.","journal-title":"J Allergy Clin Immunol"},{"key":"499_CR17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1182\/blood.V68.2.455.455","volume":"68","author":"M Berrettini","year":"1986","unstructured":"Berrettini M, Lammle B, White T, et al. Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies. Blood. 1986;68:455\u201361.","journal-title":"Blood"},{"key":"499_CR18","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nri2800","volume":"10","author":"DJ Cua","year":"2010","unstructured":"Cua DJ, Tato CM. Innate IL-17 producing cells: the sentinels of the immune system. Nat Rev Immunol. 2010;10:479\u201389.","journal-title":"Nat Rev Immunol"},{"key":"499_CR19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/imr.12036","volume":"252","author":"LA Zuniga","year":"2013","unstructured":"Zuniga LA, Jain R, Haines C, Cua DJ. Th17 cell development: from the cradle to the grave. Immunol Rev. 2013;252:78\u201388.","journal-title":"Immunol Rev"},{"key":"499_CR20","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/ni.1783","volume":"10","author":"BR Marks","year":"2009","unstructured":"Marks BR, Nowyhed HN, Choi JY, et al. Thymic self-reactivity selects natural interleukin 17-producing cells thet can regulate peripheral inflammation. Nat Immunol. 2009;10:1125\u201332.","journal-title":"Nat Immunol"},{"issue":"2","key":"499_CR21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/ar2392","volume":"10","author":"S Romagnani","year":"2008","unstructured":"Romagnani S. Human Th17 cells. Arthr Res Therapy. 2008;10(2):206 (Review).","journal-title":"Arthr Res Therapy"},{"issue":"6","key":"499_CR22","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/ni1467","volume":"8","author":"EV Acosta-Rodriguez","year":"2007","unstructured":"Acosta-Rodriguez EV, Rivino L, Geginat J, et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol. 2007;8(6):639\u201346.","journal-title":"Nat Immunol"},{"issue":"12","key":"499_CR23","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/ni1539","volume":"8","author":"MJ McGeachy","year":"2007","unstructured":"McGeachy MJ, Bak-Jensen KS, Chen Y, et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol. 2007;8(12):1390\u20137.","journal-title":"Nat Immunol"},{"key":"499_CR24","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","volume":"27","author":"T Korn","year":"2009","unstructured":"Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol. 2009;27:485\u2013517 (Review).","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"499_CR25","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.it.2011.08.003","volume":"32","author":"CM Wilke","year":"2011","unstructured":"Wilke CM, Bishop K, Fox D, Zou W. Deciphering the role of Th17 cells in human disease. Trends Immunol. 2011;32(12):603\u201311.","journal-title":"Trends Immunol"},{"key":"499_CR26","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nature05970","volume":"448","author":"T Korn","year":"2001","unstructured":"Korn T, Bettelli E, Gao W, et al. IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells. Nature. 2001;448:484\u20137.","journal-title":"Nature"},{"key":"499_CR27","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/nature01355","volume":"421","author":"DJ Cua","year":"2003","unstructured":"Cua DJ, Sherlock J, Chen Y, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 2003;421:744\u20138.","journal-title":"Nature"},{"key":"499_CR28","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1084\/jem.20041257","volume":"201","author":"CL Langrish","year":"2005","unstructured":"Langrish CL, Chen Y, Blumenschein WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 2005;201:233\u201340.","journal-title":"J Exp Med"},{"key":"499_CR29","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1084\/jem.20061308","volume":"203","author":"SC Liang","year":"2006","unstructured":"Liang SC, Tan XY, Luxenberg DP, et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med. 2006;203:2271\u20139.","journal-title":"J Exp Med"},{"key":"499_CR30","doi-asserted-by":"publisher","first-page":"5943","DOI":"10.1073\/pnas.0911755107","volume":"107","author":"MS Alam","year":"2010","unstructured":"Alam MS, Maekawa Y, Kitamura A, et al. Notch signaling drives IL-22 secretion in CD4+\u2009T cells by stimulating the aryl hydrocarbon receptor. Proc Natl Acad Sci USA. 2010;107:5943\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"499_CR31","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature05505","volume":"445","author":"Y Zheng","year":"2007","unstructured":"Zheng Y, Danilenko DM, Valdez P. Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. 2007;445:648\u201351.","journal-title":"Nature"},{"key":"499_CR32","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/ni1539","volume":"8","author":"MJ McGeachy","year":"2007","unstructured":"McGeachy MJ, Bak-Jensen KS, Chen Y, et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10by T cells and restrain Th17 cell-mediated pathology. Nat Immunol. 2007;8:1390\u20137.","journal-title":"Nat Immunol"},{"key":"499_CR33","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nature10228","volume":"465","author":"E Esplugues","year":"2011","unstructured":"Esplugues E, Huber S, Gagliani N, et al. Control of Th17cells occurs in the small intestine. Nature. 2011;465:514\u20138.","journal-title":"Nature"},{"key":"499_CR34","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/ni.1698","volume":"10","author":"MJ McGeachy","year":"2009","unstructured":"McGeachy MJ, Chen Y, Tato CM, et al. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17\u2014producing effector T helper cells\u00a0in vivo. Nat Immunol. 2009;10:314\u201324.","journal-title":"Nat Immunol"},{"key":"499_CR35","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nri3707","volume":"14","author":"SL Gaffen","year":"2014","unstructured":"Gaffen SL, Jain R, Garg AV, Cua DJ. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol. 2014;14:585\u2013600.","journal-title":"Nat Rev Immunol"},{"key":"499_CR36","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1172\/JCI25308","volume":"116","author":"Y Chen","year":"2006","unstructured":"Chen Y, Langrish CL, McKenzie B, et al. Anti IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Investig. 2006;116:1317\u201326.","journal-title":"J Clin Investig"},{"key":"499_CR37","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.1128\/IAI.00621-06","volume":"74","author":"AA Chackerian","year":"2006","unstructured":"Chackerian AA, Chen SJ, Brodie SJ, et al. Neutralization or absence of interleukin 23 pathway does not compromise immunity to mycobacterial infection. Infect Immun. 2006;74:6092\u20139.","journal-title":"Infect Immun"},{"key":"499_CR38","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.4049\/jimmunol.173.3.1887","volume":"173","author":"LA Lieberman","year":"2004","unstructured":"Lieberman LA, Cardillo F, Owyang AM, et al. IL 23 provides a limited meccanism of resistance to acute toxoplasmosis in the absence of IL-12. J Immunol. 2004;173:1887\u201393.","journal-title":"J Immunol"},{"key":"499_CR39","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.0105-2896.2006.00420.x","volume":"212","author":"MG Roncarolo","year":"2006","unstructured":"Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev. 2006;212:28\u201350.","journal-title":"Immunol Rev"},{"issue":"10","key":"499_CR40","doi-asserted-by":"publisher","first-page":"6226","DOI":"10.4049\/jimmunol.0900123","volume":"182","author":"J Xu","year":"2009","unstructured":"Xu J, Yang Y, Qiu G, et al. c-Maf regulates IL-10 expression during Th17 polarization. J Immunol. 2009;182(10):6226\u201336.","journal-title":"J Immunol"},{"issue":"10","key":"499_CR41","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1002\/art.27622","volume":"62","author":"J Leipe","year":"2010","unstructured":"Leipe J, Grunke M, Dechant C, et al. Role of Th17 cells in human autoimmune arthritis. Arthr Rheumatol. 2010;62(10):2876\u201385.","journal-title":"Arthr Rheumatol"},{"issue":"12","key":"499_CR42","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1084\/jem.20030152","volume":"198","author":"W Chen","year":"2003","unstructured":"Chen W, Jin W, Hardegen N, et al. Conversion of peripheral CD4+\u2009CD25- naive T cells to CD4+\u2009CD25+\u2009regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med. 2003;198(12):1875\u201386.","journal-title":"J Exp Med"},{"key":"499_CR43","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/j.1398-9995.2007.01427.x","volume":"10","author":"M Bas","year":"2007","unstructured":"Bas M, Adams V, Suvorava T, Niehues T, Hoffmann TK, Kojda G. Nonallergic angioedema: role of bradykinin. Allergy. 2007;10:842\u201356.","journal-title":"Allergy"},{"key":"499_CR44","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1172\/JCI119009","volume":"98","author":"ZK Pan","year":"1996","unstructured":"Pan ZK, Zuraw BL, Lung CC, Prossnitz ER, Browning DD, Ye RD. Bradykinin stimulates NF-kappaB activation and interleukin 1-beta gene expression in cultured human fibroblasts. J Clin Investig. 1996;98:2042\u20139.","journal-title":"J Clin Investig"},{"key":"499_CR45","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1582-4934.2009.00992.x","volume":"15","author":"V Brovkovych","year":"2011","unstructured":"Brovkovych V, Zhang Y, Brovkovych S, Minshall RD, Skidgel RA. A novel pathway for receptor-mediated post-translational activation of inducible nitric oxide synthase. J Cell Mol Med. 2011;15:258\u201369.","journal-title":"J Cell Mol Med"},{"key":"499_CR46","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/cei.12314","volume":"177","author":"ZL Hofman","year":"2014","unstructured":"Hofman ZL, Relan A, Hack CE. C-rective protein levels in hereditary angioedema. Clin Exp Immunol. 2014;177:280\u20136.","journal-title":"Clin Exp Immunol"},{"key":"499_CR47","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/cei.12413","volume":"178","author":"A Uzawa","year":"2014","unstructured":"Uzawa A, Mori M, Taniguchi J, Kuwabara S. Modulation of kallikrein\/kinin system by the angiotensin-converting enzyme inhibitor alleviates experimental autoimmune encephalomyelitis. Clin Exp Immunol. 2014;178:245\u201352.","journal-title":"Clin Exp Immunol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10238-018-0499-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-018-0499-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-018-0499-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T09:18:45Z","timestamp":1571044725000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10238-018-0499-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,6]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["499"],"URL":"https:\/\/doi.org\/10.1007\/s10238-018-0499-0","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"value":"1591-8890","type":"print"},{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,6]]},"assertion":[{"value":"9 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}